Skip to main content
Screener/Healthcare/Biotechnology

KROS — Keros Therapeutics, Inc.

NASDAQ
$11.56-0.17 (-1.45%)
Small CapUnder $20Healthcare
$9.69
$22.55
$11.50
$11.82
EPS (TTM)$-1.95
P/E Ratio4.44
Dividend Yield—
Market Cap$358.1M
Volume43K
Prev Close$11.73
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$367K-$23.7M$-0.63-9.8%-6459.9%
Q4 '25$385K-$23.5M$-0.38-3.9%-6093.8%
Q3 '25$14.3M-$7.3M$-0.1897.2%-51.0%
Q2 '25$18.2M-$30.7M$-0.7698.0%-169.0%
Q1 '25$211.2M$148.5M$3.62100.0%70.3%
Q4 '24$3.0M-$46.0M$-1.1489.1%-1513.0%
Q3 '24$388K-$53.0M$-1.4719.1%-13648.5%
Q2 '24$37K-$45.3M$-1.25100.0%-122316.2%
Get Your Daily Market Recap